Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-08-02

Clinical Trial Update: Aerosolized Plus Intravenous vs. Intravenous Colistin for VAP Due to Pandrugs-resistant A. Baumannii in Neonates [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating aerosolized plus intravenous colistin versus intravenous colistin alone for ventilator-associated pneumonia due to pandrug-resistant …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Colistin (colistin)

Snippet

Sponsor: Hat Yai Medical Education Center | Conditions: Pneumonia, Ventilator-Associated, Colistin Adverse Reaction | Phase 3 | Status: TERMINATED